PPT-Withdrawal of pharmacological therapy for heart failure in recovered dilated cardiomyopathy

Withdrawal of pharmacological therapy for heart failure in recovered dilated cardiomyopathy a randomised trial TREDHF Brian P Halliday MBChB PhD On behalf of Sanjay K Prasad PI John GF Cleland coPI. Gender differences and similarities. Lynette W. . Lissin. , MD FACC. Palo Alto Medical Foundation. April 21, 2012. Goals. Epidemiology and types of heart failure. Differences in incidence, clinical characteristics, prognosis in women vs. men. Michelle A. Hart MD CCFP . M.Sc.C.H. . Sid Feldman MD CCFP FCFP. Baycrest Health Sciences, Toronto, ON. Department of Family and Community Medicine,. University of Toronto. Faculty/Presenter Disclosure. What Role does genetics play?. . April 1. st. , 2013. Heart Failure Education Series. David N.. Edwards, M.D. Ph.D. F.A.C.C.. Advanced Heart Care, PA. The Heart Hospital Baylor Plano. Family History. Dr. . Naser. Ashraf . Department of Basic Medical Sciences . College of Medicine . Majmaah University . Objectives . List major drug groups used in treatment of heart failure . Explain mechanism of action of digitalis and its major effects . Study day November 2015Overview and IntroductionThis course is an introduction and overview of heart failure Normal heart function and basic pathophysiologyof heart failure is explained This will be TRED-HF. Brian P Halliday . MBChB PhD. On behalf of . Sanjay K Prasad (PI). ,. John GF Cleland (co-PI). , Rebecca Wassall, Amrit Lota, Zohya Khalique, John Gregson, Dudley J Pennell, Stuart D Rosen, Martin R Cowie and the TRED-HF investigators . Department of internal medicine 1. with course of cardio-vascular pathology. disease of the heart muscle in which the heart loses its ability to. pump blood effectively. the heart muscle becomes . Nonischemic. /Familial dilated cardiomyopathy. Myocardial ischemia. Valvular disease. Peripartum. cardiomyopathy. Toxin. Non-dilated. Myocarditis. Myocardial ischemia. Valvular disease. Infiltrative cardiomyopathy. in the Molecular Motors. that . Power . the Heart. Myosin Molecular . Motor. David M. Warshaw, Ph.D.. Molecular Physiology & Biophysics. Hank Gathers. Reggie Lewis. Genetic Defects in Myosin Motor. Akash Srinivasan. as14317@ic.ac.uk. Shortness of Breath. Heart Failure. Cardiomyopathy. . . Constrictive pericarditis. Myocarditis. Shortness of Breath. Poor removal of CO2. . . Poor delivery of oxygen. 395 respiratory or cardiac failure. Among them, cardiovascular involvement is a leading cause of morbidity and mortality. There are relatively few cases reporting cardiac pISSN 2384-1095eISSN 2384-11 ProfessorGovernmentexpress SL.NO TITLE PAGE.NO 1. INTRODUCTION 1 2. AIMS AND OBJECTIVES 4 3. REVIEW OF LITERATURE 5 4. MATERIALS AND METHODS 41 5. OBSERVATION AND RESULTS 45 6. DISCUSSION 61 7. , MD, MHA. Consultant Heart Failure & Transplantation. Heart failure is an enormous medical and societal burden . More than 2% of the U.S. population, or almost 5 million people, are affected,. It consumes approximately 2% of the National Health Service budget in the United Kingdom, and in the United States, . Beldhuis. , Peter van der Meer, Jan A. . Krikken. , . Douwe. . Postmus. , Jenifer E. . Coster. , . Wybe. . Nieuwland. , Dirk J. van . Veldhuisen. , . Adriaan. A. Voors, Kevin Damman. University of Groningen, University Medical Center Groningen, The Netherlands.